Ocular manifestations of graft-versus-host disease: 10 years’ experience

Xihui Lin, Harrison Dwight Cavanagh Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX, USA Purpose: To evaluate the ocular presentation, treatment, and clinical course of graft-versus-host disease (GVHD). Design: Retrospective case series. Participants: Two h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lin X, Cavanagh HD
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/2c30a5b26443477b93181ed2e93f7e07
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2c30a5b26443477b93181ed2e93f7e07
record_format dspace
spelling oai:doaj.org-article:2c30a5b26443477b93181ed2e93f7e072021-12-02T04:54:57ZOcular manifestations of graft-versus-host disease: 10 years’ experience1177-5483https://doaj.org/article/2c30a5b26443477b93181ed2e93f7e072015-07-01T00:00:00Zhttp://www.dovepress.com/ocular-manifestations-of-graft-versus-host-disease-10-yearsrsquo-exper-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Xihui Lin, Harrison Dwight Cavanagh Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX, USA Purpose: To evaluate the ocular presentation, treatment, and clinical course of graft-versus-host disease (GVHD). Design: Retrospective case series. Participants: Two hundred and forty-nine patients with systemic GVHD were included in the study. Methods: Ocular and systemic data were collected from 2003 to 2013. Main outcome measures: Mortality, visual acuity, and response of ocular symptoms. Results: Sixty-four patients had ocular manifestations (25.7%). At presentation, the mean age was 44.5 years and mean latency was 16.4 months. The most common presentations were keratoconjunctivitis sicca, cataract, blepharitis, ocular hypertension, and filamentary keratitis. Visual acuity at presentation was 20/49; at the worst point in the disease was 20/115; and at most recent visit was 20/63. When topical anti-inflammatory drops were used in addition to tears, 54.3% of patients’ ocular symptoms stabilized. When autologous serum was used in addition, 80% stabilized. The overall 10-year mortality of GVHD was 29.7%. For those with ocular involvement, it was 21.9%. Conclusion: Systemic GVHD has a high mortality rate, but ocular involvement does not suggest a worse prognosis. The main ocular presentations were keratoconjunctivitis sicca, cataracts, and ocular hypertension. Dry eyes in this population were very severe with overall worsening in visual acuity. However, with a step-wise approach involving topical anti-inflammatory medications and autologous serum tears, ocular symptoms do improve. It is important to monitor these patients closely, as they are prone to serious ocular complications such as corneal perforation and endophthalmitis. Keywords: dry eye, keratitis, corneal ulcerationLin XCavanagh HDDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2015, Iss default, Pp 1209-1213 (2015)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Lin X
Cavanagh HD
Ocular manifestations of graft-versus-host disease: 10 years’ experience
description Xihui Lin, Harrison Dwight Cavanagh Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX, USA Purpose: To evaluate the ocular presentation, treatment, and clinical course of graft-versus-host disease (GVHD). Design: Retrospective case series. Participants: Two hundred and forty-nine patients with systemic GVHD were included in the study. Methods: Ocular and systemic data were collected from 2003 to 2013. Main outcome measures: Mortality, visual acuity, and response of ocular symptoms. Results: Sixty-four patients had ocular manifestations (25.7%). At presentation, the mean age was 44.5 years and mean latency was 16.4 months. The most common presentations were keratoconjunctivitis sicca, cataract, blepharitis, ocular hypertension, and filamentary keratitis. Visual acuity at presentation was 20/49; at the worst point in the disease was 20/115; and at most recent visit was 20/63. When topical anti-inflammatory drops were used in addition to tears, 54.3% of patients’ ocular symptoms stabilized. When autologous serum was used in addition, 80% stabilized. The overall 10-year mortality of GVHD was 29.7%. For those with ocular involvement, it was 21.9%. Conclusion: Systemic GVHD has a high mortality rate, but ocular involvement does not suggest a worse prognosis. The main ocular presentations were keratoconjunctivitis sicca, cataracts, and ocular hypertension. Dry eyes in this population were very severe with overall worsening in visual acuity. However, with a step-wise approach involving topical anti-inflammatory medications and autologous serum tears, ocular symptoms do improve. It is important to monitor these patients closely, as they are prone to serious ocular complications such as corneal perforation and endophthalmitis. Keywords: dry eye, keratitis, corneal ulceration
format article
author Lin X
Cavanagh HD
author_facet Lin X
Cavanagh HD
author_sort Lin X
title Ocular manifestations of graft-versus-host disease: 10 years’ experience
title_short Ocular manifestations of graft-versus-host disease: 10 years’ experience
title_full Ocular manifestations of graft-versus-host disease: 10 years’ experience
title_fullStr Ocular manifestations of graft-versus-host disease: 10 years’ experience
title_full_unstemmed Ocular manifestations of graft-versus-host disease: 10 years’ experience
title_sort ocular manifestations of graft-versus-host disease: 10 years’ experience
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/2c30a5b26443477b93181ed2e93f7e07
work_keys_str_mv AT linx ocularmanifestationsofgraftversushostdisease10yearsrsquoexperience
AT cavanaghhd ocularmanifestationsofgraftversushostdisease10yearsrsquoexperience
_version_ 1718400997541281792